Treatment of arginase 1 deficiency.
TN2024000315A1Undetermined Publication Date: 2026-07-01IMMEDICA PHARMA AB
Patent Information
- Authority / Receiving Office
- TN · TN
- Patent Type
- Applications
- Current Assignee / Owner
- IMMEDICA PHARMA AB
- Filing Date
- 2024-10-09
- Publication Date
- 2026-07-01
Abstract
A method of treating Arginase 1 (ARG1) deficiency (ARG1-D) in a subject, comprising administering a pegzilarginase to the subject, wherein the pegzilarginase is a pegylated human arginase 1 comprising a cobalt metal cofactor, and wherein the pegzilarginase is administered weekly at a dose of from about 0.05 mg / kg to about 0.2 mg / kg.
Need to check novelty before this filing date? Find Prior Art